rs119472026
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001363711.2(DUOX2):c.1300C>T(p.Arg434*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R434R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001363711.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- thyroid dyshormonogenesis 6Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- familial thyroid dyshormonogenesisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DUOX2 | ENST00000389039.11 | c.1300C>T | p.Arg434* | stop_gained | Exon 12 of 34 | 1 | NM_001363711.2 | ENSP00000373691.7 | ||
| DUOX2 | ENST00000603300.1 | c.1300C>T | p.Arg434* | stop_gained | Exon 12 of 34 | 1 | ENSP00000475084.1 | |||
| DUOX2 | ENST00000558383.1 | n.2465C>T | non_coding_transcript_exon_variant | Exon 7 of 17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000676 AC: 17AN: 251472 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Thyroid dyshormonogenesis 6 Pathogenic:4
- -
- -
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1300C>T (p.R434*) alteration, located in exon 12 (coding exon 11) of the DUOX2 gene, consists of a C to T substitution at nucleotide position 1300. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 434. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been detected in individuals with congenital hypothyroidism, in the homozygous state and in the heterozygous state without a second alteration identified (Cangul, 2014; Moreno, 2002; Wang, 2020). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg434*) in the DUOX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOX2 are known to be pathogenic (PMID: 12110737, 18765513, 21565790, 24423310, 24735383). This variant is present in population databases (rs119472026, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital hypothyroidism (PMID: 12110737, 24127536). ClinVar contains an entry for this variant (Variation ID: 4062). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at